CorMedix Inc (NASDAQ: CRMD) is 52.84% higher on its value in year-to-date trading and has touched a low of $2.89 and a high of $13.85 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CRMD stock was last observed hovering at around $12.42 in the last trading session, with the day’s loss setting it -0.04%.
Currently trading at $12.38, the stock is 17.55% and 23.66% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.59 million and changing -0.32% at the moment leaves the stock 70.50% off its SMA200. CRMD registered 286.88% gain for a year compared to 6-month gain of 162.85%. The firm has a 50-day simple moving average (SMA 50) of $10.0044 and a 200-day simple moving average (SMA200) of $7.2231.
The stock witnessed a 47.03% loss in the last 1 month and extending the period to 3 months gives it a 0.24%, and is 1.73% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.81% over the week and 6.04% over the month.
CorMedix Inc (CRMD) has around 82 employees, a market worth around $751.18M and $12.26M in sales. Fwd P/E is 24.84. Profit margin for the company is -376.35%. Distance from 52-week low is 328.37% and -10.61% from its 52-week high. The company has generated returns on investments over the last 12 months (-78.08%).
with sales reaching $27.46M over the same period.The EPS is expected to grow by 54.95% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
CorMedix Inc (CRMD) Top Institutional Holders
140.0 institutions hold shares in CorMedix Inc (CRMD), with institutional investors hold 32.51% of the company’s shares. The shares outstanding are 60.68M, and float is at 59.25M with Short Float at 11.82%. Institutions hold 32.09% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 3.55 million shares valued at $15.39 million. The investor’s holdings represent 6.1796% of the CRMD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 2.9 million shares valued at $12.57 million to account for 5.0476 of the shares outstanding. The other top investors are ELLIOTT INVESTMENT MANAGEMENT L.P. which holds 1.55 million shares representing 2.6964% and valued at over $6.71 million, while NOMURA HOLDINGS INC holds 2.4733 of the shares totaling 1.42 million with a market value of $6.16 million.
CorMedix Inc (CRMD) Insider Activity
The most recent transaction is an insider purchase by Mistry Erin, the company’s EVP, Chief Commercial Officer. SEC filings show that Mistry Erin bought 1,500 shares of the company’s common stock on Oct 31 ’24 at a price of $9.99 per share for a total of $14985.0. Following the purchase, the insider now owns 52011.0 shares.
CorMedix Inc disclosed in a document filed with the SEC on Nov 14 ’24 that Hurlburt Elizabeth (EVP) sold a total of 140,027 shares of the company’s common stock. The trade occurred on Nov 14 ’24 and was made at $11.18 per share for $1.57 million. Following the transaction, the insider now directly holds 45397.0 shares of the CRMD stock.
Still, SEC filings show that on Nov 14 ’24, Hurlburt Elizabeth (Officer) Proposed Sale 140,027 shares at an average price of $11.12 for $1.56 million. The insider now directly holds shares of CorMedix Inc (CRMD).
